UNIVERSITY OF VERMONT & STATE AGRICULTURAL COLLEGE
Grant: $1,683,578 - National Institutes of Health - Jul. 20, 2009
No votes have been cast for this award yet
Join the conversation: Post a comment about this award
Award Description: This is the second competitive renewal for this Program Project Grant. During the first two cycles, the focus has been on the molecular and cellular pathways that regulate the balance of Th1 and Th2 cytokine patterns. This Program Project combines the expertise of two institutions, The University of Vermont (UVM) and the nearby Trudeau Institute. The UVM investigators have expertise is cell signaling, immunogenetics, and viral immunology, whereas the Trudeau investigators have strength in immune memory and in vivo infectious models. The renewal application makes an intentional application of our previous studies to in vivo infectious diseases. The central theme is the process by which infectious agents engage the innate immune system to influence the generation and fate of effector CD4 T cells. Of particular interest is the interface between innate and adaptive immune responses. Project 1 (Dr. Cory Teuscher) studies newly discovered roles for histamine and the four histamine receptors expressed by CD4 T cells during the transition from naïve to effector to memory CD4 T cell, as well as promoting Th1 or Th2 cytokine profiles. Project 2 (Dr. Ralph Budd) examines ?? T cell in humans and mice in response to infection, their ability to recognize non-polymorphic CD1 molecules, which are upregulated following interactions of infectious organisms. In turn, the ?? T cells activate dendritic cells to produce cytokines and costimulatory molecules that are important to the activation of naïve CD4 T cells. Project 3 (Dr. Mercedes Rincòn) examines the role of IL-6 in upregulating IL-21 by CD4 T cells, which promotes antibody production and survival by B cells. This will be applied to the influenza model.
Project Description: This is the second competitive renewal for this Program Project Grant. During the first two cycles, the focus has been on the molecular and cellular pathways that regulate the balance of Th1 and Th2 cytokine patterns. This Program Project combines the expertise of two institutions, The University of Vermont (UVM) and the nearby Trudeau Institute. The UVM investigators have expertise is cell signaling, immunogenetics, and viral immunology, whereas the Trudeau investigators have strength in immune memory and in vivo infectious models. The renewal application makes an intentional application of our previous studies to in vivo infectious diseases. The central theme is the process by which infectious agents engage the innate immune system to influence the generation and fate of effector CD4 T cells. Of particular interest is the interface between innate and adaptive immune responses. Project 1 (Dr. Cory Teuscher) studies newly discovered roles for histamine and the four histamine receptors expressed by CD4 T cells during the transition from naïve to effector to memory CD4 T cell, as well as promoting Th1 or Th2 cytokine profiles. Project 2 (Dr. Ralph Budd) examines ?? T cell in humans and mice in response to infection, their ability to recognize non-polymorphic CD1 molecules, which are upregulated following interactions of infectious organisms. In turn, the ?? T cells activate dendritic cells to produce cytokines and costimulatory molecules that are important to the activation of naïve CD4 T cells. Project 3 (Dr. Mercedes Rincòn) examines the role of IL-6 in upregulating IL-21 by CD4 T cells, which promotes antibody production and survival by B cells. This will be applied to the influenza model.
Jobs Summary: 00 (Total jobs reported: 0)
Project Status: Less Than 50% Completed
This award's data was last updated on Jul. 20, 2009. Help expand these official descriptions using the wiki below.
No comments have been added for this project.